loadpatents
Patent applications and USPTO patent grants for Jordan; R. Scott.The latest application filed is for "fixed dose combination of brimonidine and timolol".
Patent | Date |
---|---|
Fixed Dose Combination Of Brimonidine And Timolol App 20180078500 - Jiao; Jim ;   et al. | 2018-03-22 |
Enhanced Bimatoprost Ophthalmic Solution App 20160354384 - CHANG; CHIN-MING ;   et al. | 2016-12-08 |
Enhanced Bimatoprost Ophthalmic Solution App 20160250225 - Chang; Chin-Ming ;   et al. | 2016-09-01 |
Enhanced bimatoprost ophthalmic solution Grant 9,241,918 - Chang , et al. January 26, 2 | 2016-01-26 |
Enhanced Bimatoprost Ophthalmic Solution App 20160015717 - CHANG; CHIN-MING ;   et al. | 2016-01-21 |
Enhanced bimatoprost ophthalmic solution Grant 9,155,716 - Chang , et al. October 13, 2 | 2015-10-13 |
Enhanced Bimatoprost Ophthalmic Solution App 20150087713 - Chang; Chin-Ming ;   et al. | 2015-03-26 |
Enhanced bimatoprost ophthalmic solution Grant 8,933,127 - Chang , et al. January 13, 2 | 2015-01-13 |
Enhanced bimatoprost ophthalmic solution Grant 8,933,120 - Chang , et al. January 13, 2 | 2015-01-13 |
Enhanced bimatoprost ophthalmic solution Grant 8,772,338 - Chang , et al. July 8, 2 | 2014-07-08 |
Enhanced Bimatoprost Ophthalmic Solution App 20140100287 - Chang; Chin-Ming ;   et al. | 2014-04-10 |
Enhanced bimatoprost ophthalmic solution Grant 8,586,630 - Chang , et al. November 19, 2 | 2013-11-19 |
Enhanced bimatoprost ophthalmic solution Grant 8,524,777 - Chang , et al. September 3, 2 | 2013-09-03 |
Enhanced Bimatoprost Ophthalmic Solution App 20130203854 - Chang; Chin-Ming ;   et al. | 2013-08-08 |
Enhanced Bimatoprost Ophthalmic Solution App 20130197093 - CHANG; Chin-Ming ;   et al. | 2013-08-01 |
Enhanced Bimatoprost Ophthalmic Solution App 20130102678 - Chang; Chin-Ming ;   et al. | 2013-04-25 |
Enhanced Bimatoprost Ophthalmic Solution App 20130079414 - Chang; Chin-Ming ;   et al. | 2013-03-28 |
Enhanced bimatoprost ophthalmic solution Grant 8,338,479 - Chang , et al. December 25, 2 | 2012-12-25 |
Enhanced Bimatoprost Ophthalmic Solution App 20120316243 - Chang; Chin-Ming ;   et al. | 2012-12-13 |
Enhanced Bimatoprost Ophthalmic Solution App 20120289603 - Chang; Chin-Ming ;   et al. | 2012-11-15 |
Enhanced bimatoprost ophthalmic solution Grant 8,309,605 - Chang , et al. November 13, 2 | 2012-11-13 |
Enhanced bimatoprost ophthalmic solution Grant 8,299,118 - Chang , et al. October 30, 2 | 2012-10-30 |
Enhanced bimatoprost ophthalmic solution Grant 8,278,353 - Chang , et al. October 2, 2 | 2012-10-02 |
Enhanced Cimatoprost Ophthalmic Solution App 20120142782 - Chang; Chin-Ming ;   et al. | 2012-06-07 |
Enhanced Bimatoprost Ophthalmic Solution App 20120142783 - Chang; Chin-Ming ;   et al. | 2012-06-07 |
Enhanced Bimatoprost Ophthalmic Solution App 20110124737 - Chang; Chin-Ming ;   et al. | 2011-05-26 |
Enhanced bimatoprost ophthalmic solution Grant 7,851,504 - Chang , et al. December 14, 2 | 2010-12-14 |
Enhanced Bimatoprost Ophthalmic Solution App 20090149546 - Chang; Chin-Ming ;   et al. | 2009-06-11 |
Therapeutic Lacrimal Canalicular Inserts And Related Methods App 20080038317 - Chang; Chin-Ming ;   et al. | 2008-02-14 |
Enhanced bimatoprost ophthalmic solution App 20060211770 - Chang; Chin-Ming ;   et al. | 2006-09-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.